Published in Oncology Business Week, February 22nd, 2009
"To date, several folate-based chemotherapeutics and imaging probes such as radiopharmaceuticals for single photon emission computed tomography (SPECT) have been developed. However, an F-18-labeled folic acid derivative suitable for positron emission tomography (PET) imaging that can be routinely applied is still lacking....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week